Hirano Yoko, Kanda Shoichiro, Hidaka Moe, Kato Motohiro, Nishikawa Masako, Yatomi Yutaka, Tanaka Hiroyuki, Kinumaki Akiko, Kajiho Yuko, Harita Yutaka
Department of Pediatrics, The University of Tokyo, Tokyo, JPN.
Department of Clinical Laboratory Medicine, The University of Tokyo, Tokyo, JPN.
Cureus. 2024 Feb 11;16(2):e54026. doi: 10.7759/cureus.54026. eCollection 2024 Feb.
Post-biopsy bleeding is the primary complication of renal biopsy. Retroperitoneal haematoma is a rare but severe bleeding complication; it commonly occurs among patients who have risk factors or vascular lesions. The bleeding risks in patients with immunoglobulin A (IgA) nephropathy (IgAN) have been discussed in the literature, but clinical data are lacking. Here, we report a case of a post-biopsy retroperitoneal haematoma accompanied by decreased coagulation factor XIII (FXIII) in a patient with IgAN. A 14-year-old male patient with haematuria and proteinuria but no bleeding or family history of bleeding underwent pre-renal biopsy evaluation that showed no coagulation abnormalities. He underwent percutaneous renal biopsy, and the histopathological diagnosis was IgAN. Five days after the biopsy, he presented with delayed bleeding from a retroperitoneal haematoma. During the workup for undiagnosed haemorrhagic diatheses, a mildly decreased FXIII level was discovered. This result suggested the possibility of bleeding complications associated with decreased FXIII. Some bleeding diatheses, including FXIII deficiency, cannot be evaluated in routine pre-biopsy coagulation tests. Mild FXIII deficiency can increase the risk of post-biopsy bleeding complications. Therefore, physicians should consider unevaluated haemorrhagic diatheses when a patient presents with major bleeding complications or delayed bleeding following renal biopsy without any known risk factors or vascular lesions.
肾活检后出血是肾活检的主要并发症。腹膜后血肿是一种罕见但严重的出血并发症;它通常发生在有危险因素或血管病变的患者中。免疫球蛋白A(IgA)肾病(IgAN)患者的出血风险在文献中已有讨论,但临床数据尚缺乏。在此,我们报告一例IgAN患者肾活检后发生腹膜后血肿并伴有凝血因子XIII(FXIII)降低的病例。一名14岁男性患者,有血尿和蛋白尿,但无出血或出血家族史,肾活检前评估未发现凝血异常。他接受了经皮肾活检,组织病理学诊断为IgAN。活检后5天,他出现腹膜后血肿延迟出血。在对未确诊的出血性疾病进行检查时,发现FXIII水平轻度降低。这一结果提示了与FXIII降低相关的出血并发症的可能性。一些出血性疾病,包括FXIII缺乏症,在常规肾活检前凝血检查中无法评估。轻度FXIII缺乏会增加肾活检后出血并发症的风险。因此,当患者在肾活检后出现严重出血并发症或延迟出血且无任何已知危险因素或血管病变时,医生应考虑未评估的出血性疾病。